Answers are grounded in this paper and cite their sources.
Identifies risk factors for cerebral hyperperfusion syndrome in adults with moyamoya disease, indicating prompt treatment preserves clinical prognosis.
The concentration of moyamoya vessels and left operated hemisphere was independent risk factors for CHS, which could not affect the clinical prognosis if treated timely and properly. The current study offers a new perspective of moyamoya vessels and supporting data for choosing MMD candidates on cerebral revascularization.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: